Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area ubiquitination proteasome ubiquitination'

Search results for: 'research area ubiquitination proteasome ubiquitination'

Items 21-30 of 85

Page
per page
  1. ONX-0914 (PR-957)
    A4011 ONX-0914 (PR-957)
     6 Citation
    Target: Proteasome
    Summary: Immunoproteasome inhibitor,potent and selective
      ≥29.03 mg/mL
  2. Vialinin A
    A4429 Vialinin A
    Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2
    Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor
      Soluble in DMSO
  3. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: inhibitor of Ubiquitin-Activating Enzyme (E1)
  4. Disulfiram
    A4015 Disulfiram
    Target: Aldehyde Dehydrogenases
    Summary: Dopamine β-hydroxylase inhibitor
      insoluble in H2O; ≥12 mg/mL
  5. GI 254023X
    A4436 GI 254023X
     2 Citation
    Target: ADAMs
    Summary: Selective inhibitor of ADAM10 metalloprotease
      ≥42.6 mg/mL
  6. CA-074 Me
    A8239 CA-074 Me
     7 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      insoluble in H2O; ≥19.88 mg/mL
  7. Bestatin hydrochloride
    A8621 Bestatin hydrochloride
    Target: Aminopeptidases
    Summary: Inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.
      ≥125 mg/mL
  8. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL
  9. Bestatin
    A2575 Bestatin
    Target: Aminopeptidases
    Summary: Aminopeptidase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥12.34 mg/mL
  10. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL

Items 21-30 of 85

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Specificity
  1. Selective 63item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 12item
  2. Irreversible 10item
Target
  1. Proteasome 12item
  2. Cathepsins 8item
  3. Histone Deacetylases (HDACs) 1 item
  4. PI3K 2item
  5. MDM2 1 item
  6. MMP 2item
  7. Thymidylate Synthase 1 item
  8. Deubiquitinating enzymes (DUBs) 1 item
  9. Aminopeptidases 3item
  10. Microtubules/Tubulins 2item
  11. HSP90 5item
  12. Serine Proteases 2item
  13. Calpains 5item
  14. Ubiquitin-specific proteases 1 item
  15. Trypsins 1 item
  16. Trypsin 1 item
  17. Chymotrypsin 1 item
  18. Kallikrein 1 item
  19. Trypsinogen 1 item
  20. HIV-1 gp120 1 item
  21. Fatty-acid-binding proteins (FABPs) 1 item
  22. Autophagy 1 item
  23. HIV Integrases 1 item
  24. 20S proteasomal chymotrypsin 1 item
  25. Geranylgeranyltransferase I 1 item
  26. Farnesyltransferase 1 item
  27. Aldehyde Dehydrogenases 1 item
  28. Histamine H1 Receptors 1 item
  29. IL Receptors 1 item
  30. CCL2 1 item
  31. Papains 1 item
  32. Ubiquitin-activating Enzyme E1 1 item
  33. DPP-4 4item
  34. ADAMs 1 item
  35. NMPRTase 1 item
  36. p53 1 item
  37. Ub-conjugating enzyme (E2) complex 1 item
  38. cysteine protease 2item
  39. HDM2 ubiquitin ligase 1 item
  40. integrase 1 item
  41. UCH 1 item
  42. TRPC channel 1 item
Related Disease
  1. Breast Cancer 13item
  2. Cancer 43item
  3. Cocaine-Related Disorders 1 item
  4. Colon Cancer 4item
  5. Colon Carcinoma 1 item
  6. Colorectal Cancer 1 item
  7. Diabetes 4item
  8. Glioblastoma 1 item
  9. Glioma 1 item
  10. HIV 4item
  11. HIV Infections 2item
  12. Inflammatory Diseases 2item
  13. Leukemia 1 item
  14. Lung Cancer 2item
  15. Lymphoma 1 item
  16. Mantle Cell Lymphoma 1 item
  17. Melanoma 4item
  18. Multiple Myeloma 5item
  19. Myeloma 3item
  20. Neuroblastoma 1 item
  21. Non-small Cell Lung Cancer 3item
  22. Ovarian Cancer 5item
  23. Pancreatic Cancer 2item
  24. Prostate Cancer 4item
  25. Psoriasis 1 item
  26. Renal Cell Carcinoma 1 item
  27. Rheumatoid Arthritis 2item
  28. Squamous Cell Carcinoma 1 item
  29. Type 2 Diabetes 1 item